Global Epilepsy Market 2014-2018 a New Research Report added to ReportsnReports.com

Share Article

Global Epilepsy Market 2014-2018 profiles key players like GlaxoSmithKline plc, Pfizer Inc. and UCB SA. Other prominent vendors are also profiled.

Past News Releases

RSS

One key trend in this market is the reformulation of marketed drugs. Reformulated drugs, usually, have better tolerability and better dosing schedules than the original drugs. This increases the market acceptance of such drugs, driving their market revenue.

According to the “Global Epilepsy Market 2014-2018 report" (http://www.reportsnreports.com/reports/314564-global-epilepsy-market-2014-2018.html), unmet medical needs are one of the major drivers of the market. Lack of safe, efficacious, and disease-modifying treatment is a major unmet need. Currently, drugs administered for epilepsy are intended to treat seizures. However, they fail to check the progression of the disease.

The report recognizes the following companies as the key players in the Global Epilepsy Market: GlaxoSmithKline plc, Pfizer Inc. and UCB SA.

Other Prominent Vendors in the market are: Abbvie, Eisai, F. Hoffmann-La Roche, H. Lundbeck and Janssen Pharmaceuticals.

Market Driver

  •     Unmet Medical Needs
  •     For a full, detailed list, view our report

Market Trend

  •     Reformulation of Marketed Drugs
  •     For a full, detailed list, view our report

Further, the report states that Generic erosion is one of the major challenges in the market. This, in turn, decreases the market revenue of individual drugs.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=314564.

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Epilepsy Market 2013-2018 (US$ million)
Exhibit 3: Global Epilepsy Market Segmentation by Generation of Drugs
Exhibit 4: Revenue and CAGR of Major Epilepsy Markets 2013 (US$ million)
Exhibit 5: Global Epilepsy Market by Geographical Segmentation 2013
Exhibit 6: Global Epilepsy Market by Geographical Segmentation 2018
Exhibit 7: Global Epilepsy Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 8: Global Epilepsy Market by Geographical Segmentation 2013-2018
Exhibit 9: Epilepsy Market in the Americas 2013-2018
Exhibit 10: Epilepsy Market in the Americas by Geography 2013 (US$ million)
Exhibit 11: Epilepsy Market in North America 2013-2018
Exhibit 12: Epilepsy Market in the US 2013-2018
Exhibit 13: Epilepsy Market in Canada 2013-2018
Exhibit 14: Epilepsy Market in EMEA by Geography 2013
Exhibit 15: Epilepsy Market in EMEA 2013-2018
Exhibit 16: Epilepsy Market in Europe 2013-2018
Exhibit 17: Epilepsy Market in APAC by Geography 2013
Exhibit 18: Revenue and CAGR of Epilepsy Market in APAC by Geography 2013 (US$ million)
Exhibit 19: Epilepsy Market in APAC 2013-2018
Exhibit 20: Epilepsy Market in Japan 2013-2018
Exhibit 21: Epilepsy Market in Australia 2013-2018
Exhibit 22: Epilepsy Market in China 2013-2018
Exhibit 23: Epilepsy Market in India 2013-2018
Exhibit 24: Impact of loss of exclusivity in Canadian market for Lyrica
Exhibit 25: Lyrica Revenue 2011-2013 (US$ million)
Exhibit 26: Neurontin Revenue 2011-2013 (US$ million)
Exhibit 27: Vimpat Revenue 2011-2013 (US$ million)
Exhibit 28: Vimpat Sales by Geographical Segmentation 2013
Exhibit 29: Keppra/Keppra XR Revenue 2011-2013 (US$ million)
Exhibit 30: Keppra/Keppra XR Sales by Geographical Segmentation 2013
Exhibit 31: Lamictal Revenue 2011-2013 (US$ million)
Exhibit 32: Lamictal Sales by Geographical Segmentation 2013
Exhibit 33: GlaxoSmithKline: Business Segmentation 2013
Exhibit 34: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 35: GlaxoSmithKline: Sales by Geography 2013
Exhibit 36: GlaxoSmithKline: Pipeline Products 2013
Exhibit 37: Pfizer: Business Segmentation by Revenue 2013
Exhibit 38: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 39: Pfizer: Geographical Segmentation by Revenue 2013

Other New Reports by Infiniti Research Limited:
Global Atomic Spectroscopy Market 2014-2018: Analysts forecast the Global Atomic Spectroscopy market to grow at a CAGR of 7.01 percent over the period 2013-2018.

The report covers the present scenario and the growth prospects of the Global Atomic Spectroscopy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the following major segments:

  • X-ray Diffraction
  • X-ray Fluorescence
  • Atomic Absorption
  • Elemental Analyzers
  • Inductively Coupled Plasma

Global Fungicides Market 2014-2018: Analysts forecast the Global Fungicides market to grow at a CAGR of 5.95 percent over the period 2013-2018.

The report also provides data on the different segments of the Global Fungicides market, which are based on the following criteria: type of crop, application, and geography.

Key Vendors: Syngenta, BASF, Bayer and DuPont

Other Prominent Vendors: ADAMA Agricultural Solutions, AMVAC, Cheminova, Chemtura, Dow, FMC, Isagro, Lonza, Makhteshim Agan Industries, Novozymes BioAg, Nippon Soda and Nufarm

About US
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email the details on sales at reportsandreports.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@marketsreports
since: 06/2010
Follow >
ReportsnReports
Like >
Follow us on
Visit website